Macquarie Group’s VivoSim Labs VIVS Stock Holding History

Macquarie Group’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-24	Closed	-$8K	–	2393
2017 Q4	$8K	Buy	+24	New	+$8.92K	﹤0.01%	2315

Other funds holding VIVS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Macquarie Group's VIVS Position: Q1 2018 in Review

Macquarie Group sold out of VivoSim Labs (VIVS) in Q1 2018, closing a stake of 24 shares — an estimated $8K sold.

Macquarie Group first reported a position in VIVS in Q4 2017 and held it in 1 quarter. The position peaked at $8K in Q4 2017. 105 funds tracked by Wall St. Rank hold VIVS as of Q1 2018.

Macquarie Group reported no remaining VivoSim Labs position as of Q1 2018 after selling out during the quarter.
Macquarie Group sold 24 VivoSim Labs shares in Q1 2018, an estimated $8K.
Macquarie Group first reported a position in VivoSim Labs in Q4 2017 and held it in 1 quarter.
Macquarie Group's VivoSim Labs position peaked at $8K in Q4 2017.
105 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2018.

Based on Macquarie Group's 13F filing for Q1 2018, filed 11 May 2018.